EC
| |
Euclidean Capital LLC13F | |
Euclidean Capital LLC | |
Last update 2025-02-16 | 11 Stocks (0 new) |
Value $737.00 Mil | Turnover 4 % |
Euclidean Capital LLC Top Holdings of 2024-12-31
View Full List
Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|
SPY | SPDR S&P 500 ETF Trust | 896,254 | 525,276.5 | -25.49% | 71.300 | -19.40% | 0.090 | -6.92% | -4.42% | 580,240.3 | ||
INDA | iShares MSCI India ETF | 2,425,144 | 127,659.6 | 0% | 17.330 | 0% | 1.420 | +5.00% | +1.71% | 9,074.2 | ||
VEU | Vanguard FTSE All-World ex-US ETF | 1,013,434 | 58,181.3 | +99.65% | 7.900 | +3.94% | 0.160 | +5.09% | +8.68% | 39,122.8 | ||
ORIC | ORIC Pharmaceuticals Inc | 989,410 | 7,984.5 | 0% | 1.080 | 0% | 1.400 | -46.55% | -30.98% | 395.9 | Biotechnology | |
FHTX | Foghorn Therapeutics Inc | 1,573,761 | 7,428.1 | 0% | 1.010 | 0% | 2.830 | -0.72% | -11.86% | 231.3 | Biotechnology | |
PMVP | PMV Pharmaceuticals Inc | 2,627,643 | 3,967.7 | 0% | 0.540 | 0% | 5.080 | -29.58% | -33.77% | 52.0 | Biotechnology | |
ALEC | Alector Inc | 1,307,858 | 2,471.8 | 0% | 0.340 | 0% | 1.340 | -26.51% | -35.45% | 122.0 | Biotechnology | |
TNYA | Tenaya Therapeutics Inc | 1,015,705 | 1,452.5 | 0% | 0.200 | 0% | 1.280 | -51.89% | -64.34% | 82.9 | Biotechnology | |
SRZN | Surrozen Inc | 87,696 | 1,258.4 | 0% | 0.170 | 0% | 2.700 | -9.66% | -26.97% | 89.0 | Biotechnology | |
RAPT | RAPT Therapeutics Inc | 657,899 | 1,039.5 | 0% | 0.140 | 0% | 0.500 | -19.72% | -42.08% | 120.8 | Biotechnology |
Euclidean Capital LLC's Historical Top Holdings Breakdowns
Euclidean Capital LLC's Top Stock Picks
View Full List
Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
---|---|---|---|---|---|---|---|---|---|---|---|
SPY | SPDR S&P 500 ETF Trust | 2024-12-31 | Reduce | -19.40% | 567.8 ($589.49) 607.81 | $558.47 | -5.26% | Reduce -25.49% | 896,254 | -306,550 | |
VEU | Vanguard FTSE All-World ex-US ETF | 2024-12-31 | Add | +3.94% | 57.29 ($60.21) 63.13 | $62.20 | 3.31% | Add 99.65% | 1,013,434 | 505,834 | |
MEHCQ | 23andMe Holding Co | 2024-12-31 | Sold Out | -0.40% | 2.83 ($4.29) 7.77 | $1.36 | -68.30% | Sold Out | 0 | -512,156 | |
SPY | SPDR S&P 500 ETF Trust | 2024-09-30 | Add | +3.53% | 517.38 ($552.93) 573.76 | $558.47 | 1.00% | Add 4.87% | 1,202,804 | 55,825 | |
VEU | Vanguard FTSE All-World ex-US ETF | 2024-09-30 | New Buy | +3.53% | 56.47 ($60.22) 63.69 | $62.20 | 3.29% | New holding | 507,600 | 507,600 | |
SPY | S&P 500 ETF TRUST ETF | 2024-06-30 | Add | +11.78% | 495.16 ($523.39) 548.49 | $558.47 | 6.70% | Add 17.68% | 1,146,979 | 172,338 | |
GLD | SPDR Gold Shares ETF | 2024-06-30 | Sold Out | -11.40% | 207.82 ($216.29) 224.56 | $297.46 | 37.53% | Sold Out | 0 | -432,271 | |
NGM Unlock Delisted | NGM Biopharmaceuticals Inc | 2024-06-30 | Sold Out | -0.20% | 1.54 ($1.55) 1.56 | $1.54 | -0.65% | Sold Out | 0 | -992,168 | |
GLD | SPDR Gold Shares ETF | 2024-03-31 | Reduce | -20.61% | 184.42 ($191.93) 205.72 | $297.46 | 54.98% | Reduce -68.9% | 432,271 | -957,729 | |
SPY | S&P 500 ETF TRUST ETF | 2024-03-31 | Add | +3.86% | 467.28 ($497.86) 523.17 | $558.47 | 12.17% | Add 6.27% | 974,641 | 57,500 |
Euclidean Capital LLC Total Holding History ($B)
Euclidean Capital LLC's Asset Allocation
Euclidean Capital LLC Past Portfolios
Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
---|---|---|---|---|
Top Ranked Articles
- 1
Euclidean Capital LLC's Hypothetical Growth since 2024-12-31
Euclidean Capital LLC's Yearly Returns
Year | Portfolio % | % | Excess Gain % |
---|
Euclidean Capital LLC's Holdings Heat Map
Size field:
Euclidean Capital LLC's Holdings Bubble Chart
Euclidean Capital LLC News
- 1